$MRK Recent Headlines Merck to revamp its RD pra
Post# of 89345
Posted On: 12/28/2013 3:51:20 PM
$MRK Recent Headlines
Merck to revamp its R&D practices: WSJ 4:49 p.m. Dec. 27, 2013 - Wallace Witkowski
Merck to radically reshape R&D unit: WSJ 4:40 p.m. Dec. 27, 2013 - Wallace Witkowski
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Dec. 23, 2013 - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Why Merck Is Planning to Change Its Research Strategy 2:05 p.m. Today - Wall St. Cheat Sheet
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
Ad Com scheduled for Merck's ragweed immunotherapy 8:36 a.m. Dec. 27, 2013 - Seeking Alpha
Merck Sues to Stop Generic NuvaRing 3:50 p.m. Dec. 26, 2013 - benzinga.com
Merck Becomes #15 Most Shorted Dow Stock, Replacing Johnson & Johnson 11:17 a.m. Dec. 26, 2013 - TheStreet.com
Dow Today: Microsoft Corporation (MSFT) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Dec. 26, 2013 - TheStreet.com
Merck Sues Actavis Over Generic NuvaRing 9:44 a.m. Dec. 25, 2013 - Wall St. Cheat Sheet
Dividends: Big Dogs, Small Dogs And Spy Dogs 4:11 a.m. Dec. 25, 2013 - Seeking Alpha
Will Merck Be Able To Sustain Its Dividends? 3:55 p.m. Dec. 24, 2013 - Seeking Alpha
TESARO Plunges on Study Results - Analyst Blog 11:30 a.m. Dec. 24, 2013 - Zacks.com
Where Will GlaxoSmithKline Go Next? 10:50 a.m. Dec. 24, 2013 - Wall St. Cheat Sheet
Dow Dogs Drink To A Dominant 2013. Will They Toast A Triumphant 2014, Too? 10:38 a.m. Dec. 24, 2013 - Seeking Alpha
Cervical Cancer Should Not Be Ignored By Biotech Investors 9:59 a.m. Dec. 24, 2013 - Seeking Alpha
Actavis unit gets CRL for contraceptive patch, files ANDA for generic NuvaRing 9:12 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
48 Last-Minute Trades Before Christmas 4:07 a.m. Dec. 24, 2013 - InvestorPlace.com
Update on Sanofi/REGN's Alirocumab - Analyst Blog 5:20 p.m. Dec. 23, 2013 - Zacks.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha
Top 10 Dow Dividend Stocks for December 6:00 a.m. Dec. 23, 2013 - InvestorPlace.com
New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Dec. 20, 2013 - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
Merck to revamp its R&D practices: WSJ 4:49 p.m. Dec. 27, 2013 - Wallace Witkowski
Merck to radically reshape R&D unit: WSJ 4:40 p.m. Dec. 27, 2013 - Wallace Witkowski
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Dec. 23, 2013 - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Why Merck Is Planning to Change Its Research Strategy 2:05 p.m. Today - Wall St. Cheat Sheet
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
Ad Com scheduled for Merck's ragweed immunotherapy 8:36 a.m. Dec. 27, 2013 - Seeking Alpha
Merck Sues to Stop Generic NuvaRing 3:50 p.m. Dec. 26, 2013 - benzinga.com
Merck Becomes #15 Most Shorted Dow Stock, Replacing Johnson & Johnson 11:17 a.m. Dec. 26, 2013 - TheStreet.com
Dow Today: Microsoft Corporation (MSFT) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Dec. 26, 2013 - TheStreet.com
Merck Sues Actavis Over Generic NuvaRing 9:44 a.m. Dec. 25, 2013 - Wall St. Cheat Sheet
Dividends: Big Dogs, Small Dogs And Spy Dogs 4:11 a.m. Dec. 25, 2013 - Seeking Alpha
Will Merck Be Able To Sustain Its Dividends? 3:55 p.m. Dec. 24, 2013 - Seeking Alpha
TESARO Plunges on Study Results - Analyst Blog 11:30 a.m. Dec. 24, 2013 - Zacks.com
Where Will GlaxoSmithKline Go Next? 10:50 a.m. Dec. 24, 2013 - Wall St. Cheat Sheet
Dow Dogs Drink To A Dominant 2013. Will They Toast A Triumphant 2014, Too? 10:38 a.m. Dec. 24, 2013 - Seeking Alpha
Cervical Cancer Should Not Be Ignored By Biotech Investors 9:59 a.m. Dec. 24, 2013 - Seeking Alpha
Actavis unit gets CRL for contraceptive patch, files ANDA for generic NuvaRing 9:12 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
48 Last-Minute Trades Before Christmas 4:07 a.m. Dec. 24, 2013 - InvestorPlace.com
Update on Sanofi/REGN's Alirocumab - Analyst Blog 5:20 p.m. Dec. 23, 2013 - Zacks.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha
Top 10 Dow Dividend Stocks for December 6:00 a.m. Dec. 23, 2013 - InvestorPlace.com
New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Dec. 20, 2013 - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
(0)
(0)